Fosun Pharma to sell 2.85M NATR shares at $12; company may repurchase up to $15M

NATURES SUNSHINE PRODUCTS INC

Secondary offering of 2,854,607 shares by selling stockholder Fosun Pharma USA at $12.00 per share.
Company receives no proceeds from the offering; shares sold entirely by Fosun Pharma.
Company may purchase up to $15M of offered shares from underwriters; no minimum commitment.
Offering expected to close June 27, 2025; 90-day lock-up for insiders and selling stockholder.
Concurrent share repurchase authorized by Board and Audit Committee; shares cancelled if repurchased.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.